CX-046684 for Covid-19 prophylaxis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where CX-046684 was used for Covid-19 prophylaxis.
Most Reported Side Effects for CX-046684
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 23 | 46.0% | 0 | 6 |
| Off label use | 15 | 30.0% | 0 | 3 |
| Covid-19 | 14 | 28.0% | 0 | 4 |
| Headache | 13 | 26.0% | 0 | 2 |
| Asthenia | 12 | 24.0% | 0 | 4 |
| Muscular weakness | 12 | 24.0% | 0 | 7 |
| Pain in extremity | 11 | 22.0% | 0 | 3 |
| Dysphagia | 10 | 20.0% | 0 | 2 |
| Dyspnoea | 10 | 20.0% | 0 | 3 |
| Fall | 10 | 20.0% | 0 | 4 |
| Drug ineffective | 9 | 18.0% | 0 | 3 |
| Insomnia | 9 | 18.0% | 0 | 3 |
| Gait disturbance | 8 | 16.0% | 0 | 1 |
| Malaise | 8 | 16.0% | 0 | 1 |
| Peripheral swelling | 8 | 16.0% | 0 | 2 |
Other Indications for CX-046684
Other Drugs Used for Covid-19 prophylaxis
CILGAVIMAB\TIXAGEVIMAB (1,105)
COVID-19 VACCINE NOS (583)
TOZINAMERAN (377)
ELASOMERAN (152)
ALCOHOL (136)
AZD-1222 (105)
AD26.COV2.S (64)
COVID-19 VACCINE (52)
HYDROXYCHLOROQUINE (52)
CASIRIVIMAB\IMDEVIMAB (51)